Chiasso, Switzerland – 21 May 2026 – Dipharma SA, a Swiss pharmaceutical company developing high-quality, improved medicines for rare diseases, is proud to announce that it has been ranked #7 in the Top Workplaces in Europe 2025 list by Best Place...

Founder & CEO Marc-Olivier Geinoz discusses why the company has chosen the largely unexplored rare diseases generics space and the opportunities in metabolic diseases. Marc-Olivier Geinoz – CEO, Dipharma SA Dipharma SA is a Swiss specialty pha...